Quick Answer
Caribou Biosciences, Inc. reported Total Assets of $175.37 million for fiscal year 2025.
Caribou Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $175.37M | -44.0% |
| 2024 | $313.31M | -27.5% |
| 2023 | $432.21M | +15.6% |
| 2022 | $373.76M | -15.5% |
| 2021 | $442.36M | +1127.2% |
| 2020 | $36.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $194.98M | -43.4% | -11.7% |
| June 30, 2025 | $220.90M | -40.8% | -19.3% |
| March 31, 2025 | $273.66M | -32.7% | -12.7% |
| December 31, 2024 | $313.31M | -27.5% | -9.0% |
| September 30, 2024 | $344.33M | -24.7% | -7.7% |
| June 30, 2024 | $372.94M | +6.7% | -8.3% |
| March 31, 2024 | $406.82M | +17.1% | -5.9% |
| December 31, 2023 | $432.21M | +15.6% | -5.5% |
- Caribou Biosciences, Inc. showed a decrease of -44.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Caribou Biosciences, Inc.’s total assets has grown by 386.5% (from $36.05 million to $175.37 million).
- The most recent figure is from Caribou Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: